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ABSTRACT
With advancement in genetic studies, familial phaeochromocytoma (PCC) and paraganglioma (PGL) 
are increasingly being recognized. Characteristically, correlations exist between genotypes and clinical 
and biochemical phenotypes. We report a phaeochromocytoma in a young patient with intriguing family 
histories, raising the possibility of his being a familial case.
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INTRODUCTION
Phaeochromocytomas (PCC) and paraganglioma (PGL) are catecholamine-producing chromaffin cell tumours of the 
adrenal medulla and extra-adrenal sympathetic paraganglia, respectively.1 PGL usually arise in the abdomen and are 
functional, in contrast to those in the head and neck regions.2 PCC/PGL is a rare cause of hypertension, accounting for 
0.1-0.6% of cases.3 Owing to its non-specific symptoms, which are shared by many other diseases, phaeochromocytoma 
is aptly nicknamed as “the great mimic”.2 This often leads to a delayed or even missed diagnosis, as reflected by a 
relatively higher prevalence in autopsy studies than in general population, at 0.05% and 0.015-0.04%, respectively.3
CASE REPORT
A 30 year old gentleman presented to Accident and Emergency department, feeling unwell, with headache, excessive 
sweating and palpitation. He recalled having them intermittently for the past five years. His father died of a heart 
attack whilst one of his paternal uncles had a sudden death, both in their 50s. His brother is also a hypertensive. On 
examination, his blood pressure was elevated at 204/140. ECG showed normal sinus rhythm with evidence of left 
ventricular hypertrophy, whilst his echocardiogram was normal. Renal artery stenosis was ruled out by abdominal 
ultrasound.     
CT abdomen (Figure 1) showed a right adrenal mass, measuring 3.7 x 2.5 cm, which was suggestive of 
phaeochromocytoma. His 24-h urinary fractionated catecholamines (Figure 2 and Table 1) showed elevated level of 
noradrenaline; whilst those of adrenaline and dopamine were within normal limits (Noradrenaline = 1363 µg/24h; 
adrenaline <3.0 µg/24h; Dopamine = 242 µg/24h).     
                                 
Figure 1: Abdominal scan showing a right adrenal mass (→)
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Figure 2: The chromatogram of 24-hour urinary fractionated catecholamines
Table 1: 24-hour urinary fractionated catecholamine
Noradrenaline 1362.7   (12.1-85.5 µg/24 h)
Adrenaline <3.0 (1.7-22.4 µg/24 h)
Dopamine 242 (<498 µg/24 h)
Based on his classical clinical presentation, positive CT findings and elevated urinary catecholamines, a diagnosis of 
phaeochromocytoma was made. Post-operatively, the tumour was histologically confirmed and he was on a lifelong 
follow-up. 
It was recently discovered that one of his paternal cousins had succumbed to a metastatic tumour of unknown 
origin. Thus this case may represent a case of familial phaeochromocytoma, given the above-mentioned family 
histories. 
DISCUSSION
In his case, other causes of secondary hypertension such as Cushing’s syndrome, renal artery stenosis and 
hyperthyroidism were ruled out by normal findings of random cortisol, abdominal ultrasonography and thyroid 
function test, respectively. The classical symptoms of headaches, palpitations, and diaphoresis, if occur in triad in a 
hypertensive patient, is highly suggestive of PCC/PGL.4 Clinically, the nature of his hypertension, which was sustained 
rather than paroxysmal, was suggestive of a noradrenaline-producing tumour. 
Biochemical evidence of catecholamine overproduction is crucial for diagnosing phaeochromocytoma. 
Traditionally, this is achieved by urinary fractionated catecholamines (UFC). Unlike the parent catecholamine, the 
intra-tumoural production and secretion of the metabolite is continuous and independent.2 Thus their measurement as 
either plasma free metanephrine (PFM) or urinary fractionated metanephrine (UFM) is more sensitive than that of the 
parent amine.2 However, as UFM reflects the sulfate-conjugates of metanephrines, which are mainly gastrointestinal 
and not tumour in origin, PFM gives a higher diagnostic specificity.1,5 
PFM is preferred by some authors to be used in high-risk population such as suspected familial PCC/PGL.3 
However, a normal PFM can be seen in strictly dopamine-secreting tumours.3 Others believe that the choice of test 
should consider local expertise and experience as well as availability of the method of measurement.3 Regardless, 
proper patient and sample preparation are of paramount importance for a valid interpretation of the results. 
Recently, the traditional rule of 10% has been genetically challenged whereby up to 30% of cases are now shown 
to be hereditary, with 13 genes identified.1 Syndromic familial PCC/PGLs occur in multiple endocrine neoplasia-2 
(MEN-2), von Hippel-Lindau syndrome (VHL), neurofibromatosis type 1 (NF-1) and the familial paragangliomas; 
due to mutations of Rearranged Transfection (RET), VHL, NF-1 and the succinate dehydrogenase (SDH) subunits 
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(B, C, D) genes, respectively.1 The latter is collectively known as SDHx.1 SDHA mutation, on the other hand, is 
non-syndromic.1 Interestingly, familial PCC/PGLs have been shown to display characteristic phenotype-genotype 
correlations.1,2 
Genetically, familial PCC/PGL can be divided into “Cluster 1” (VHL and SDHx) or “Cluster 2” (MEN-2, NF-
1), which are suggestive by their biochemical profiles and locations.1 Adrenal tumours are most likely to be “Cluster 
2” and are adrenergic in nature.1 An exception is VHL which is usually noradrenergic despite being intra-adrenal.1 
In addition, solely noradrenaline-producing tumours point strongly to VHL.1 In contrast, SDHx mutations are rarely 
adrenal and in addition to noradrenaline, they can also secrete dopamine.1 
NF1 is usually diagnosed on clinical grounds, with no available genetic testing.4 Being adrenaline-secreting, 
measurement of free metanephrines is superior in differentiating MEN-2 from “Cluster 1” tumours.5 As SHDB or D 
may secrete dopamine, measurement of its metabolite, the free 3-methoxytyramine further distinguishes VHL from 
SHDx.5 In addition, the marker is potentially useful in detection of metastatic diseases.1,3
Factors that suggested a familial phaeochromocytoma in this patient include age<35 and suspicious family 
histories of sudden and tumour-related deaths, premature CVD and hypertension.4 It is notable that all deaths occurred 
on his paternal side.
Despite being intra-adrenal, his strictly noradrenaline-secreting tumour was suggestive of VHL. However, VHL-
associated features such as renal cyst were not found on imaging. Unlike MEN-2, in which the associated medullary 
thyroid carcinoma and primary hyperparathyroidism can be screened by serum calcitonin and calcium, respectively, 
biochemical screening has limited use in VHL. Such tests may include non-specific urinalysis and full blood count, 
looking for haematuria and polycythaemia, respectively.
A possible case of familial PCC mandates a life-long follow-up, during which a detailed family history would 
help us elucidate further the likelihood of and the most likely genetic mutation. Furthermore, VHL are often bilateral 
which may occur at different times. 
In conclusion, phaeochromocytomas are rare causes of hypertension with a devastating consequence in an 
event of a missed diagnosis. A possibility of a familial case should always be borne in mind. Although hypertension 
and cardiovascular disease (CVD) are common, premature CVD, sudden death and cancer-related death should raise 
suspicion. A definitive diagnosis of such, however, relies upon genetic testing, which is costly and unfortunately 
unavailable in Malaysia. Nevertheless, knowledge of the phenotype-genotype correlations should enable us to 
discriminately and cost-effectively utilize biochemical and genetic screening. 
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